ArticleMicrobiology spectrum2026
A photoactivation-free viability PCR reagent for rapid, culture-independent detection of live bacteria.
Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Detection of viable bacteria in complex samples is a long-standing challenge in microbiology and public health. Traditional culture methods are slow and often fail to capture viable but non-culturable cells, while PCR-based methods can overestimate bacterial loads by amplifying DNA from non-viable (dead) cells. To address this challenge, we evaluated a novel, photoactivation-free viability PCR (vPCR) reagent from Promega Corporation that selectively crosslinks DNA from non-viable cells, rendering it unamplifiable by qPCR. This approach enables accurate, culture-independent quantification of viable bacteria. We optimized key parameters in both gram-positive ( IMPORTANCE: Rapid and reliable detection of viable bacteria is essential for protecting public health, monitoring water quality, ensuring food safety, and advancing clinical diagnostics. Conventional culture methods underestimate viable cells and require days to deliver results, while conventional PCR-based tests cannot distinguish viable (live) from non-viable (dead) organisms. Here, we describe a photoactivation-free viability PCR reagent that overcomes these limitations by selectively blocking PCR amplification from non-viable cells. Using
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.